Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: April 2011

Chapter 16 - Mechanisms of pain transmission and transduction

References

1. Gasser HS, Erlanger J. The role played by the sizes of the constituent fibers of a nerve-trunk in determining the form of its action potencial wave. Am J Physiol 1927; 80: 522–47.
2. Willis WD, Coggeshall RE. Sensory Mechanisms of the Spinal Cord, 2nd edn. New York, NY: Plenum Press, 1991.
3. Rexed B. The cytoarchetectonic organization of the spinal cord in the rat. J Comp Neurol 1952; 96: 415–466.
4. Neumann S, Braz JM, Skinner K, Llewellyn-Smith IJ, Basbaum AI. Innocuous, not noxious, input activates PKCgamma interneurons of the spinal dorsal horn via myelinated afferent fibers. J Neurosci 2008; 28: 7936–44.
5. Zylka MJ, Rice FL, Anderson DJ. Topographically distinct epidermal nociceptive circuits revealed by axonal tracers targeted to Mrgprd. Neuron 2005; 45(1): 17–25.
6. Todd AJ. Chapter 6 Anatomy and neurochemistry of the dorsal horn. Handb Clin Neurol 2006; 81: 61–76.
7. Willis WD, Al-Chaer ED, Quast MJ, Westlund KN. A visceral pain pathway in the dorsal column of the spinal cord. Proc Natl Acad Sci U S A 1999; 96: 7675–9.
8. Burstein R, Cliffer KD, Giesler GJ. Cells of origin of the spinohypothalamic tract in the rat. J Comp Neurol 1990; 291: 329–44.
9. Burstein R, Potrebic S. Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat. J Comp Neurol 1993; 335: 469–85.
10. Dostrovsky JO, Craig AD. Ascending projection systems. In: McMahon SB, Koltzenburg M, eds., Wall and Melzack's Textbook of Pain, 5th edn. Philadelphia, PA: Elsevier/Churchill Livingstone, 2005: 187–204.
11. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969; 164: 444–5.
12. Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science 1973; 179: 1011–14.
13. Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res 1975; 88: 295–308.
14. Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004; 27: 729–37.
15. Fields HL, Basbaum AI, Heinricher MM. Central nervous system mechanisms of pain modulation. In: McMahon SB, Koltzenburg M, eds., Wall and Melzack's Textbook of Pain, 5th edn. Philadelphia, PA: Elsevier/Churchill Livingstone, 2005: 125–142.
16. Gebhart GF. Can endogenous systems produce pain? APS Journal 1992; 1: 79–81.
17. Andrews PL, Sanger GJ. Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr Opin Pharmacol 2002; 2: 650–6.
18. Zagon A. Does the vagus nerve mediate the sixth sense? Trends Neurosci 2001; 24: 671–3.
19. Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut 2002; 51 (Suppl 1): i2–5.
20. Loeser J, Bonica J, Butler S. Bonica's Management of Pain. Philadelphia, PA: Lippincott Williams & Wilkins, 2001.
21. Morgan G, Mikhail M, Murray M. Clinical Anesthesiology, 4th edn. New York, NY: McGraw-Hill, 2005.
22. Patestas M, LPG. A Textbook of Neuroanatomy. Malden, MA: Wiley-Blackwell, 2006.
23. Blair NT, Bean BP. Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J Neurosci 2002; 22: 10277–90.
24. Snider WD, McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron 1998; 20: 629–32.
25. Lawson SN. The postnatal development of large light and small dark neurons in mouse dorsal root ganglia: a statistical analysis of cell numbers and size. J Neurocytol 1979; 8: 275–94.
26. Gobel S. Golgi studies of the neurons in layer II of the dorsal horn of the medulla (trigeminal nucleus caudalis). J Comp Neurol 1978; 180: 395–413.
27. Grudt TJ, Perl ER. Correlations between neuronal morphology and electrophysiological features in the rodent superficial dorsal horn. J Physiol 2002; 540: 189–207.
28. Maxwell DJ, Belle MD, Cheunsuang O, Stewart A, Morris R. Morphology of inhibitory and excitatory interneurons in superficial laminae of the rat dorsal horn. J Physiol 2007; 584: 521–33.
29. Kato G, Kawasaki Y, Ji RR, Strassman AM. Differential wiring of local excitatory and inhibitory synaptic inputs to islet cells in rat spinal lamina II demonstrated by laser scanning photostimulation. J Physiol 2007; 580: 815–33.
30. Yasaka T, Kato G, Furue H, et al. Cell-type-specific excitatory and inhibitory circuits involving primary afferents in the substantia gelatinosa of the rat spinal dorsal horn in vitro. J Physiol 2007; 581: 603–18.
31. Carrasquillo Y, Gereau RW. Rodent models clarify the role of cells expressing the substance P receptor in pain. Drug Discov Today Dis Models 2004; 1: 107–113.
32. Lu Y, Perl ER. Modular organization of excitatory circuits between neurons of the spinal superficial dorsal horn (laminae I and II). J Neurosci 2005; 25: 3900–7.
33. Hu HJ, Alter BJ, Carrasquillo Y, Qiu CS, Gereau RW. Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons. J Neurosci 2007; 27: 13181–91.
34. Sandkuhler J. Understanding LTP in pain pathways. Mol Pain 2007; 3: 9.
35. Knabl J, Witschi R, Hosl K, et al. Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 2008; 451: 330–4.
36. Patapoutian A, Peier AM, Story GM, Viswanath V. ThermoTRP channels and beyond: mechanisms of temperature sensation. Nat Rev Neurosci 2003; 4: 529–39.
37. Story GM, Peier AM, Reeve AJ, et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 2003; 112: 819–29.
38. Story GM, Gereau RW. Numbing the senses: role of TRPA1 in mechanical and cold sensation. Neuron 2006; 50: 177–80.
39. Sutherland SP, Benson CJ, Adelman JP, McCleskey EW. Acid-sensing ion channel 3 matches the acid-gated current in cardiac ischemia-sensing neurons. Proc Natl Acad Sci U S A 2001; 98: 711–16.
40. Cervero F, Laird JM. Understanding the signaling and transmission of visceral nociceptive events. J Neurobiol 2004; 61: 45–54.
41. Immke DC, McCleskey EW. Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neurons. Nat Neurosci 2001; 4: 869–70.
42. Chen CC, Zimmer A, Sun WH, Hall J, Brownstein MJ. A role for ASIC3 in the modulation of high-intensity pain stimuli. Proc Natl Acad Sci U S A 2002; 99: 8992–7.
43. Drew LJ, Rohrer DK, Price MP, et al. Acid-sensing ion channels ASIC2 and ASIC3 do not contribute to mechanically activated currents in mammalian sensory neurones. J Physiol 2004; 556: 691–710.
44. Mamet J, Baron A, Lazdunski M, Voilley N. Proinflammatory mediators, stimulators of sensory neuron excitability via the expression of acid-sensing ion channels. J Neurosci 2002; 22: 10662–70.
45. Cho H, Shin J, Shin CY, Lee SY, Oh U. Mechanosensitive ion channels in cultured sensory neurons of neonatal rats. J Neurosci 2002; 22: 1238–47.
46. Drew LJ, Wood JN, Cesare P. Distinct mechanosensitive properties of capsaicin-sensitive and -insensitive sensory neurons. J Neurosci 2002; 22: RC228.
47. McCleskey EW, Gold MS. Ion channels of nociception. Annu Rev Physiol 1999; 61: 835–56.
48. Krafte DS, Bannon AW. Sodium channels and nociception: recent concepts and therapeutic opportunities. Curr Opin Pharmacol 2008; 8: 50–6.
49. Nassar MA, Baker MD, Levato A, et al. Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice. Mol Pain 2006; 2: 33.
50. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006; 444: 894–8.
51. Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006; 52: 767–74.
52. Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004; 41: 171–4.
53. Renganathan M, Cummins TR, Waxman SG. Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 2001; 86: 629–40.
54. Zimmermann K, Leffler A, Babes A, et al. Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures. Nature 2007; 447: 855–8.
55. Nassar MA, Levato A, Stirling LC, Wood JN. Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8. Mol Pain 2005; 1: 24.
56. Lai J, Gold MS, Kim CS, et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, Nav1.8. Pain 2002; 95: 143–52.
57. Joshi SK, Mikusa JP, Hernandez G, et al. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states. Pain 2006; 123: 75–82.
58. Dong XW, Goregoaker S, Engler H, et al. Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats. Neuroscience 2007; 146: 812–21.
59. Jarvis MF, Honore P, Shieh CC, et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A 2007; 104: 8520–5.
60. Amaya F, Wang H, Costigan M, et al. The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci 2006; 26: 12852–60.
61. Priest BT, Murphy BA, Lindia JA, et al. Contribution of the tetrodotoxin-resistant voltage-gated sodium channel Nav1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci U S A 2005; 102: 9382–7.
62. Momin A, Wood JN. Sensory neuron voltage-gated sodium channels as analgesic drug targets. Curr Opin Neurobiol 2008; 18: 383–8.
63. Cao YQ. Voltage-gated calcium channels and pain. Pain 2006; 126: 5–9.
64. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87: 543–52.
65. Grasshoff C, Antkowiak B. Effects of isoflurane and enflurane on GABAA and glycine receptors contribute equally to depressant actions on spinal ventral horn neurones in rats. Br J Anaesth 2006; 97: 687–94.
66. Solt K, Forman SA. Correlating the clinical actions and molecular mechanisms of general anesthetics. Curr Opin Anaesthesiol 2007; 20: 300–6.
67. Collins JG, Kendig JJ, Mason P. Anesthetic actions within the spinal cord: contributions to the state of general anesthesia. Trends Neurosci 1995; 18: 549–53.
68. Antognini JF, Kien ND. Potency (minimum alveolar anesthetic concentration) of isoflurane is independent of peripheral anesthetic effects. Anesth Analg 1995; 81: 69–72.
69. Sun YY, Li KC, Chen J. Evidence for peripherally antinociceptive action of propofol in rats: behavioral and spinal neuronal responses to subcutaneous bee venom. Brain Res 2005; 1043: 231–5.
70. Matta JA, Cornett PM, Miyares RL, et al. General anesthetics activate a nociceptive ion channel to enhance pain and inflammation. Proc Natl Acad Sci U S A 2008; 105: 8784–9.
71. Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994; 80: 606–10.
72. Borges M, Antognini JF. Does the brain influence somatic responses to noxious stimuli during isoflurane anesthesia? Anesthesiology 1994; 81: 1511–15.
73. Kishikawa K, Uchida H, Yamamori Y, Collins JG. Low-threshold neuronal activity of spinal dorsal horn neurons increases during REM sleep in cats: comparison with effects of anesthesia. J Neurophysiol 1995; 74: 763–9.
74. Baars JH, Benzke M, von Dincklage F, et al. Presynaptic and postsynaptic effects of the anesthetics sevoflurane and nitrous oxide in the human spinal cord. Anesthesiology 2007; 107: 553–62.
75. Jinks SL, Bravo M, Hayes SG. Volatile anesthetic effects on midbrain-elicited locomotion suggest that the locomotor network in the ventral spinal cord is the primary site for immobility. Anesthesiology 2008; 108: 1016–24.
76. Grasshoff C, Rudolph U, Antkowiak B. Molecular and systemic mechanisms of general anaesthesia: the “multi-site and multiple mechanisms” concept. Curr Opin Anaesthesiol 2005; 18: 386–91.
77. Antognini JF, Wang XW, Piercy M, Carstens E. Propofol directly depresses lumbar dorsal horn neuronal responses to noxious stimulation in goats. Can J Anaesth 2000; 47: 273–9.
78. Eger EI, Koblin DD, Harris RA, et al. Hypothesis: inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth Analg 1997; 84: 915–8.
79. Kendig JJ. In vitro networks: subcortical mechanisms of anaesthetic action. Br J Anaesth 2002; 89: 91–101.
80. Sonner JM, Antognini JF, Dutton RC, et al. Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth Analg 2003; 97: 718–40.
81. Eger EI, Raines DE, Shafer SL, Hemmings HC, Sonner JM. Is a new paradigm needed to explain how inhaled anesthetics produce immobility? Anesth Analg 2008; 107: 832–48.
82. Merrill AW, Barter LS, Rudolph U, et al. Propofol's effects on nociceptive behavior and spinal c-fos expression after intraplantar formalin injection in mice with a mutation in the gamma-aminobutyric acid-type(A) receptor beta3 subunit. Anesth Analg 2006; 103: 478–83.
83. Merkel G, Eger EI. A comparative study of halothane and halopropane anesthesia including method for determining equipotency. Anesthesiology 1963; 24: 346–57.
84. Alford S, Schwartz E, Viana di Prisco G. The pharmacology of vertebrate spinal central pattern generators. Neuroscientist 2003; 9: 217–28.
85. Cheng G, Kendig JJ. Enflurane directly depresses glutamate AMPA and NMDA currents in mouse spinal cord motor neurons independent of actions on GABAA or glycine receptors. Anesthesiology 2000; 93: 1075–84.
86. Yanagidate F, Strichartz GR. Bupivacaine inhibits activation of neuronal spinal extracellular receptor-activated kinase through selective effects on ionotropic receptors. Anesthesiology 2006; 104: 805–14.
87. Olschewski A, Hempelmann G, Vogel W, Safronov BV. Blockade of Na+ and K+ currents by local anesthetics in the dorsal horn neurons of the spinal cord. Anesthesiology 1998; 88: 172–9.
88. Komai H, McDowell TS. Local anesthetic inhibition of voltage-activated potassium currents in rat dorsal root ganglion neurons. Anesthesiology 2001; 94: 1089–95.
89. Kindler CH, Yost CS. Two-pore domain potassium channels: new sites of local anesthetic action and toxicity. Reg Anesth Pain Med 2005; 30: 260–74.
90. Xiong Z, Strichartz GR. Inhibition by local anesthetics of Ca2+ channels in rat anterior pituitary cells. Eur J Pharmacol 1998; 363: 81–90.
91. Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology 2000; 93: 858–75.
92. Hollmann MW, Herroeder S, Kurz KS, et al. Time-dependent inhibition of G protein-coupled receptor signaling by local anesthetics. Anesthesiology 2004; 100: 852–60.
93. Hollmann MW, McIntire WE, Garrison JC, Durieux ME. Inhibition of mammalian Gq protein function by local anesthetics. Anesthesiology 2002; 97: 1451–7.
94. Hollmann MW, Wieczorek KS, Berger A, Durieux ME. Local anesthetic inhibition of G protein-coupled receptor signaling by interference with Galpha(q) protein function. Mol Pharmacol 2001; 59: 294–301.
95. Minami K, Uezono Y. Gq protein-coupled receptors as targets for anesthetics. Curr Pharm Des 2006; 12: 1931–7.
96. Uratsuji Y, Nakanishi H, Takeyama Y, Kishimoto A, Nishizuka Y. Activation of cellular protein kinase C and mode of inhibitory action of phospholipid-interacting compounds. Biochem Biophys Res Commun 1985; 130: 654–61.
97. Mikawa K, Maekawa N, Hoshina H, et al. Inhibitory effect of barbiturates and local anaesthetics on protein kinase C activation. J Int Med Res 1990; 18: 153–60.
98. Yanagidate F, Strichartz GR. Local anesthetics. Handb Exp Pharmacol 2007; (177): 95–127.
99. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 81624.
100. Leffler A, Fischer MJ, Rehner D, et al. The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J Clin Invest 2008; 118: 763–76.
101. Hirota K, Smart D, Lambert DG. The effects of local and intravenous anesthetics on recombinant rat VR1 vanilloid receptors. Anesth Analg 2003; 96: 1656–60.
102. Binshtok AM, Bean BP, Woolf CJ. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 2007; 449: 607–10.
103. Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain. 2008 Feb; 24: 142–54.
104. Gunthorpe MJ, Chizh BA. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today 2009; 14: 56–67.
105. Hefti FF, Rosenthal A, Walicke PA, et al. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 2006; 27: 85–91.
106. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 1994 Dec 1; 6: 1903–12.
107. Della Seta D, de Acetis L, Aloe L, Alleva E. NGF effects on hot plate behaviors in mice. Pharmacol Biochem Behav 1994 Nov; 49: 701–5.
108. Zhu CZ, Wilson SG, Mikusa JP, et al. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol 2004; 506: 107–18.
109. Bhave G, Karim F, Carlton SM, Gereau RW. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 2001; 4: 417–23.
110. Lea PM, Faden AI. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev 2006; 12: 149–166.
111. Karim F, Wang CC, Gereau RW. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001; 21: 3771–9.
112. Hu HJ, Bhave G, Gereau RW. Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. J Neurosci, 2002; 22: 7444–7452.
113. Hudson LJ, Bevan S, McNair K, et al. Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci 2002; 22: 2660–8.
114. Walker K, Reeve A, Bowes M, et al. mGlu5 receptors and nociceptive function II: mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology 2001; 40: 10–19.
115. Montana MC, Cavallone LF, Stubbert KK, et al. The mGlu5 antagonist fenobam is analgesic and has improved in vivo selectivity as compared to the prototypical antagonist MPEP. J Pharmacol Exp Ther 2009; 330: 834–43.